Zkusit zdarma
Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals, Inc.

CRNX
Cena:
$ 36.80
-0.29 (-0.78%)
Valuace
70
Růst
0
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Hedge Fund Drops $37 Million on Rare Disease Biotech Crinetics. Is It a Buy?

Hedge Fund Drops $37 Million on Rare Disease Biotech Crinetics. Is It a Buy?

13:50 18-05-2026

Crinetics Pharmaceuticals develops oral therapies for rare endocrine diseases....

Crinetics Pharmaceuticals, Inc. (CRNX) Q1 2026 Earnings Call Transcript

Crinetics Pharmaceuticals, Inc. (CRNX) Q1 2026 Earnings Call Transcript

2:11 08-05-2026

Crinetics Pharmaceuticals, Inc. (CRNX) Q1 2026 Earnings Call Transcript...

Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 Loss, Beats Revenue Estimates

Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 Loss, Beats Revenue Estimates

18:55 07-05-2026

Crinetics Pharmaceuticals, Inc. (CRNX) came out with a quarterly loss of $1.23 per share versus the ...

Crinetics Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update

Crinetics Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update

16:05 07-05-2026

PALSONIFY™ (Paltusotine) Net Product Revenue of $10.3 Million for First-Quarter 2026, with 232 Enr...

Analysts Estimate Crinetics Pharmaceuticals, Inc. (CRNX) to Report a Decline in Earnings: What to Look Out for

Analysts Estimate Crinetics Pharmaceuticals, Inc. (CRNX) to Report a Decline in Earnings: What to Look Out for

11:06 30-04-2026

CRINETICS PHARM (CRNX) doesn't possess the right combination of the two key ingredients for a likely...

Crinetics Pharmaceuticals Announces the European Commission Approval of PALSONIFY® (Paltusotine) for the Treatment of Acromegaly in Adults

Crinetics Pharmaceuticals Announces the European Commission Approval of PALSONIFY® (Paltusotine) for the Treatment of Acromegaly in Adults

17:13 27-04-2026

PALSONIFY is the first once-daily, oral therapy approved to treat acromegaly in the European Union A...

Jeff Knight Sells 85,163 Shares of Crinetics Pharmaceuticals (NASDAQ:CRNX) Stock

Jeff Knight Sells 85,163 Shares of Crinetics Pharmaceuticals (NASDAQ:CRNX) Stock

4:19 12-04-2026

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX - Get Free Report) insider Jeff Knight sold 85,163 sha...

Crinetics Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026

Crinetics Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026

16:05 08-04-2026

SAN DIEGO, April 08, 2026 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today a...

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Receives Average Recommendation of “Moderate Buy” from Analysts

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Receives Average Recommendation of “Moderate Buy” from Analysts

4:43 29-03-2026

Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX - Get Free Report) have earned a consensus r...

Crinetics Director Sells 5,000 Shares With Stock Down 4%, but Here's What Matters More

Crinetics Director Sells 5,000 Shares With Stock Down 4%, but Here's What Matters More

19:56 27-03-2026

A director of Crinetics Pharmaceuticals reported that he sold 5,000 shares of the company for a tran...

Crinetics Pharmaceuticals Announces Submission of Marketing Authorization Application in Brazil for Palsonify™ (Paltusotine) in Acromegaly

Crinetics Pharmaceuticals Announces Submission of Marketing Authorization Application in Brazil for Palsonify™ (Paltusotine) in Acromegaly

16:05 26-03-2026

SAN DIEGO, March 26, 2026 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today a...

Crinetics Pharmaceuticals Highlights Early PALSONIFY Sales, EU Milestone, and GPCR Pipeline at TD Cowen Conf.

Crinetics Pharmaceuticals Highlights Early PALSONIFY Sales, EU Milestone, and GPCR Pipeline at TD Cowen Conf.

2:02 10-03-2026

Executives from Crinetics Pharmaceuticals (NASDAQ: CRNX) used an investor discussion at TD Cowen's 4...

Intech Investment Management LLC Has $926,000 Stock Position in Crinetics Pharmaceuticals, Inc. $CRNX

Intech Investment Management LLC Has $926,000 Stock Position in Crinetics Pharmaceuticals, Inc. $CRNX

5:01 09-03-2026

Intech Investment Management LLC lessened its holdings in Crinetics Pharmaceuticals, Inc. (NASDAQ: C...

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Given Consensus Rating of “Moderate Buy” by Analysts

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Given Consensus Rating of “Moderate Buy” by Analysts

4:46 07-02-2026

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX - Get Free Report) has been assigned a consensus ratin...

Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences in March

Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences in March

16:05 05-02-2026

SAN DIEGO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today a...

Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

17:00 26-01-2026

SAN DIEGO, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today an...

Crinetics Pharmaceuticals, Inc. (CRNX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Crinetics Pharmaceuticals, Inc. (CRNX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

15:56 13-01-2026

Crinetics Pharmaceuticals, Inc. (CRNX) Presents at 44th Annual J.P. Morgan Healthcare Conference Tra...

Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock

Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock

21:22 06-01-2026

SAN DIEGO, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) (“Crin...

Crinetics Pharmaceuticals touts $5M Palsonify Q4 launch, posts strong atumelnant phase 2 CAH data

Crinetics Pharmaceuticals touts $5M Palsonify Q4 launch, posts strong atumelnant phase 2 CAH data

4:32 06-01-2026

Crinetics Pharmaceuticals (NASDAQ: CRNX) provided a corporate update highlighting early commercial p...

Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock

Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock

16:02 05-01-2026

SAN DIEGO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) (“Crin...

close

CRINETICS PHARMACEUTICALS TO PARTICIPATE IN TWO UPCOMING INVESTOR CONFERENCES IN MARCH

05-02-2026
SAN DIEGO, FEB. 05, 2026 (GLOBE NEWSWIRE) -- CRINETICS PHARMACEUTICALS, INC. (NASDAQ: CRNX), TODAY A...
Více zde

CRINETICS PHARMACEUTICALS TO REPORT FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS ON FEBRUARY 26, 2026

26-01-2026
SAN DIEGO, JAN. 26, 2026 (GLOBE NEWSWIRE) -- CRINETICS PHARMACEUTICALS, INC. (NASDAQ: CRNX) TODAY AN...
Více zde

CRINETICS INITIATES PHASE 2/3 PEDIATRIC TRIAL EVALUATING ATUMELNANT IN CONGENITAL ADRENAL HYPERPLASIA (CAH)

22-01-2026
SAN DIEGO, JAN. 22, 2026 (GLOBE NEWSWIRE) -- CRINETICS PHARMACEUTICALS, INC. (NASDAQ: CRNX) TODAY AN...
Více zde

CRINETICS PHARMACEUTICALS ANNOUNCES JANUARY 2026 INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

12-01-2026
SAN DIEGO, JAN. 12, 2026 (GLOBE NEWSWIRE) -- CRINETICS PHARMACEUTICALS, INC. (NASDAQ: CRNX) TODAY AN...
Více zde

CRINETICS PHARMACEUTICALS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK

06-01-2026
SAN DIEGO, JAN. 06, 2026 (GLOBE NEWSWIRE) -- CRINETICS PHARMACEUTICALS, INC. (NASDAQ: CRNX) (“CRIN...
Více zde

CRINETICS PHARMACEUTICALS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

05-01-2026
SAN DIEGO, JAN. 05, 2026 (GLOBE NEWSWIRE) -- CRINETICS PHARMACEUTICALS, INC. (NASDAQ: CRNX) (“CRIN...
Více zde

CRINETICS ANNOUNCES STRONG PALSONIFY LAUNCH EXECUTION AND POSITIVE RESULTS FOR CONCURRENT ANDROSTENEDIONE LOWERING AND GLUCOCORTICOID DOSE REDUCTION IN PHASE 2 TRIAL OF ATUMELNANT FOR CONGENITAL ADRENAL HYPERPLASIA

05-01-2026
STRONG PALSONIFY U.S. LAUNCH EXECUTION RESULTED IN UNAUDITED AND PRELIMINARY NET PRODUCT REVENUE OF ...
Více zde

CRINETICS PHARMACEUTICALS TO PROVIDE PALSONIFY BUSINESS UPDATE AND ANNOUNCE TOPLINE RESULTS FROM FOURTH COHORT OF PHASE 2 TRIAL OF ATUMELNANT IN CONGENITAL ADRENAL HYPERPLASIA

04-01-2026
SAN DIEGO, JAN. 04, 2026 (GLOBE NEWSWIRE) -- CRINETICS PHARMACEUTICALS, INC. (NASDAQ: CRNX), TODAY A...
Více zde

CRINETICS PHARMACEUTICALS TO PARTICIPATE IN THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

18-12-2025
SAN DIEGO, DEC. 18, 2025 (GLOBE NEWSWIRE) -- CRINETICS PHARMACEUTICALS, INC. (NASDAQ: CRNX), TODAY A...
Více zde

CRINETICS ANNOUNCES FIRST PATIENT DOSED IN PIVOTAL ADULT TRIAL OF ATUMELNANT IN CONGENITAL ADRENAL HYPERPLASIA (CAH)

11-12-2025
PHASE 3 STUDY BUILDS ON POSITIVE PHASE 2 RESULTS SHOWING RAPID AND SUSTAINED REDUCTIONS IN KEY DISEA...
Více zde

CRINETICS PHARMACEUTICALS ANNOUNCES DECEMBER 2025 INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

10-12-2025
SAN DIEGO , DEC. 10, 2025 (GLOBE NEWSWIRE) -- CRINETICS PHARMACEUTICALS, INC. (NASDAQ: CRNX) TODAY A...
Více zde

CRINETICS ANNOUNCES FIRST PATIENT DOSED IN PHASE 1/2 TRIAL EVALUATING CRN09682 FOR THE TREATMENT OF NEUROENDOCRINE TUMORS AND OTHER SOMATOSTATIN RECEPTOR 2-EXPRESSING TUMORS

03-12-2025
SAN DIEGO, DEC. 03, 2025 (GLOBE NEWSWIRE) -- CRINETICS PHARMACEUTICALS, INC. (NASDAQ: CRNX) TODAY AN...
Více zde

CRINETICS ANNOUNCES FIRST PATIENT RANDOMIZED IN PIVOTAL PHASE 3 CAREFNDR TRIAL EVALUATING PALTUSOTINE IN CARCINOID SYNDROME

20-11-2025
CAREFNDR UNDERSCORES THE POTENTIAL CLINICAL VALUE OF P ALTUSOTINE B EYOND ACROMEGALY, AND DEMONSTRAT...
Více zde

CRINETICS PHARMACEUTICALS ANNOUNCES NOVEMBER 2025 INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

10-11-2025
SAN DIEGO, NOV. 10, 2025 (GLOBE NEWSWIRE) -- CRINETICS PHARMACEUTICALS, INC. (NASDAQ: CRNX) TODAY AN...
Více zde

CRINETICS PHARMACEUTICALS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

06-11-2025
PALSONIFY™ (PALTUSOTINE) LAUNCHED IN THE U.S. WITH ENCOURAGING EARLY FEEDBACK FROM PATIENTS AND PH...
Více zde

CRINETICS TO HIGHLIGHT NEUROENDOCRINE TUMOR RESEARCH PROGRESS AT THE 2025 NORTH AMERICAN NEUROENDOCRINE TUMOR SOCIETY ANNUAL MEETING

23-10-2025
PRELIMINARY ANALYSIS OF ONE-YEAR PROGRESSION-FREE SURVIVAL DATA FROM PHASE 2 STUDY OF NOVEL SST2 AGO...
Více zde

CRINETICS PHARMACEUTICALS ANNOUNCES OCTOBER 2025 INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

10-10-2025
SAN DIEGO, OCT. 10, 2025 (GLOBE NEWSWIRE) -- CRINETICS PHARMACEUTICALS, INC. (NASDAQ: CRNX) TODAY AN...
Více zde

CRINETICS PHARMACEUTICALS TO REPORT THIRD QUARTER 2025 FINANCIAL RESULTS ON NOVEMBER 6, 2025

06-10-2025
SAN DIEGO, OCT. 06, 2025 (GLOBE NEWSWIRE) -- CRINETICS PHARMACEUTICALS, INC. (NASDAQ: CRNX) TODAY AN...
Více zde

CRINETICS ANNOUNCES FDA APPROVAL OF PALSONIFY™ (PALTUSOTINE) FOR THE TREATMENT OF ADULTS WITH ACROMEGALY

25-09-2025
NOVEL NONPEPTIDE SST2 AGONIST PALSONIFY ADVANCES THE TREATMENT PARADIGM AS THE FIRST ONCE-DAILY, ORA...
Více zde

CRINETICS PHARMACEUTICALS ANNOUNCES SEPTEMBER 2025 INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

10-09-2025
SAN DIEGO, SEPT. 10, 2025 (GLOBE NEWSWIRE) -- CRINETICS PHARMACEUTICALS, INC. (NASDAQ: CRNX) TODAY A...
Více zde

CRINETICS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR ATUMELNANT IN THE TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA (CAH)

21-08-2025
SAN DIEGO, AUG. 21, 2025 (GLOBE NEWSWIRE) -- CRINETICS PHARMACEUTICALS, INC. (NASDAQ: CRNX) TODAY AN...
Více zde

CRINETICS PHARMACEUTICALS ANNOUNCES AUGUST 2025 INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

11-08-2025
SAN DIEGO, AUG. 11, 2025 (GLOBE NEWSWIRE) -- CRINETICS PHARMACEUTICALS, INC. (NASDAQ: CRNX) TODAY AN...
Více zde

CRINETICS PHARMACEUTICALS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

07-08-2025
REGULATORY INTERACTIONS AND COMMERCIAL, MEDICAL AND CORPORATE PREPARATIONS ON-TRACK FOR PALSONIFY™...
Více zde

CRINETICS TO PRESENT NEW LONG-TERM DATA DEMONSTRATING DURABLE CONTROL OF ONCE-DAILY, ORAL PALSONIFY™ (PALTUSOTINE) IN ACROMEGALY AT ENDO 2025

13-07-2025
DATA SHOW THAT PALSONIFY WAS WELL TOLERATED AND IGF-1 LEVELS REMAINED STABLY CONTROLLED DURING LONG-...
Více zde

CRINETICS PHARMACEUTICALS TO REPORT SECOND QUARTER 2025 FINANCIAL RESULTS ON AUGUST 7, 2025

11-07-2025
SAN DIEGO, JULY 11, 2025 (GLOBE NEWSWIRE) -- CRINETICS PHARMACEUTICALS, INC. (NASDAQ: CRNX) TODAY AN...
Více zde

CRINETICS PHARMACEUTICALS ANNOUNCES JULY 2025 INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

10-07-2025
SAN DIEGO, JULY 10, 2025 (GLOBE NEWSWIRE) -- CRINETICS PHARMACEUTICALS, INC. (NASDAQ: CRNX) TODAY AN...
Více zde

CRINETICS TO SHOWCASE THE NEXT GENERATION OF ENDOCRINOLOGY INNOVATION AT ENDO 2025 WITH EIGHT PRESENTATIONS FROM ITS DEEP PIPELINE

30-06-2025
LONG-TERM EFFICACY AND SAFETY DATA ON PALSONIFY TM (PALTUSOTINE) IN ACROMEGALY TO BE PRESENTED, INCL...
Více zde

CRINETICS PHARMACEUTICALS TO HOST R&D DAY ON JUNE 26, 2025

16-06-2025
SAN DIEGO, JUNE 16, 2025 (GLOBE NEWSWIRE) -- CRINETICS PHARMACEUTICALS, INC. (NASDAQ: CRNX), TODAY A...
Více zde

CRINETICS PHARMACEUTICALS ANNOUNCES JUNE 2025 INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

10-06-2025
SAN DIEGO, JUNE 10, 2025 (GLOBE NEWSWIRE) -- CRINETICS PHARMACEUTICALS, INC. (NASDAQ: CRNX) TODAY AN...
Více zde

CRINETICS PHARMACEUTICALS TO PARTICIPATE IN THE JEFFERIES GLOBAL HEALTHCARE CONFERENCE 2025

23-05-2025
SAN DIEGO, MAY 23, 2025 (GLOBE NEWSWIRE) -- CRINETICS PHARMACEUTICALS, INC. (NASDAQ: CRNX), TODAY AN...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-01-26 00:00:008-KStáhnout
2026-01-13 00:00:008-KStáhnout
2026-01-07 00:00:008-KStáhnout
2026-01-05 00:00:008-KStáhnout
2025-12-17 00:00:008-KStáhnout
2025-11-06 00:00:008-KStáhnout
2025-11-06 00:00:0010-QStáhnout
2025-09-26 01:00:008-KStáhnout
2025-09-26 00:00:008-KStáhnout
2025-08-07 01:00:008-KStáhnout
2025-08-07 01:00:0010-QStáhnout
2025-08-07 00:00:008-KStáhnout
2025-08-07 00:00:0010-QStáhnout
2025-06-30 01:00:008-KStáhnout
2025-06-30 00:00:008-KStáhnout
2025-06-26 01:00:008-KStáhnout
2025-06-26 00:00:008-KStáhnout
2025-06-12 01:00:008-KStáhnout
2025-06-12 00:00:008-KStáhnout
2025-05-08 01:00:008-KStáhnout
2025-05-08 01:00:0010-QStáhnout
2025-05-08 00:00:008-KStáhnout
2025-05-08 00:00:0010-QStáhnout
2025-04-04 01:00:008-KStáhnout
2025-04-04 00:00:008-KStáhnout
2025-02-27 00:00:008-KStáhnout
2025-02-27 00:00:0010-KStáhnout
2025-02-26 23:00:008-KStáhnout
2025-02-26 23:00:0010-KStáhnout
2025-02-24 00:00:008-KStáhnout
2025-02-23 23:00:008-KStáhnout
2025-01-14 00:00:008-KStáhnout
2025-01-13 23:00:008-KStáhnout
2025-01-10 00:00:008-KStáhnout
2025-01-09 23:00:008-KStáhnout
2024-12-16 00:00:008-KStáhnout
2024-12-15 23:00:008-KStáhnout
2024-12-09 00:00:008-KStáhnout
2024-12-08 23:00:008-KStáhnout
2024-11-12 00:00:008-KStáhnout
2024-11-12 00:00:0010-QStáhnout
2024-11-11 23:00:008-KStáhnout
2024-11-11 23:00:0010-QStáhnout
2024-10-16 01:00:008-KStáhnout
2024-10-16 00:00:008-KStáhnout
2024-10-09 01:00:008-KStáhnout
2024-10-09 00:00:008-KStáhnout
2024-09-26 01:00:008-KStáhnout
2024-09-26 00:00:008-KStáhnout
2024-09-17 01:00:008-KStáhnout
2024-09-17 00:00:008-KStáhnout
2024-08-08 01:00:008-KStáhnout
2024-08-08 01:00:0010-QStáhnout
2024-08-08 00:00:008-KStáhnout
2024-08-08 00:00:0010-QStáhnout
2024-06-21 01:00:008-KStáhnout
2024-06-21 00:00:008-KStáhnout
2024-06-10 01:00:008-KStáhnout
2024-06-10 00:00:008-KStáhnout
2024-06-03 01:00:008-KStáhnout
2024-06-03 00:00:008-KStáhnout
2024-05-22 01:00:008-KStáhnout
2024-05-22 00:00:008-KStáhnout
2024-05-09 01:00:008-KStáhnout
2024-05-09 01:00:0010-QStáhnout
2024-05-09 00:00:008-KStáhnout
2024-05-09 00:00:0010-QStáhnout
2024-05-08 01:00:008-KStáhnout
2024-05-08 00:00:008-KStáhnout
2024-04-04 01:00:008-KStáhnout
2024-04-04 00:00:008-KStáhnout
2024-03-19 00:00:008-KStáhnout
2024-03-18 23:00:008-KStáhnout
2024-03-12 00:00:008-KStáhnout
2024-03-11 23:00:008-KStáhnout
2024-03-01 00:00:008-KStáhnout
2024-02-29 23:00:008-KStáhnout
2024-02-28 00:00:008-KStáhnout
2024-02-28 00:00:0010-KStáhnout
2024-02-27 23:00:008-KStáhnout
2024-01-08 00:00:008-KStáhnout
2024-01-07 23:00:008-KStáhnout
2023-12-18 00:00:008-KStáhnout
2023-12-17 23:00:008-KStáhnout
2023-12-12 00:00:008-KStáhnout
2023-12-11 23:00:008-KStáhnout
2023-11-07 00:00:008-KStáhnout
2023-11-07 00:00:0010-QStáhnout
2023-11-06 23:00:008-KStáhnout
2023-11-06 23:00:0010-QStáhnout
2023-09-13 01:00:008-KStáhnout
2023-09-13 00:00:008-KStáhnout
2023-09-11 01:00:008-KStáhnout
2023-09-11 00:00:008-KStáhnout
2023-08-08 01:00:008-KStáhnout
2023-08-08 01:00:0010-QStáhnout
2023-08-08 00:00:008-KStáhnout
2023-08-08 00:00:0010-QStáhnout
2023-06-21 01:00:008-KStáhnout
2023-06-21 00:00:008-KStáhnout
2023-05-09 01:00:0010-QStáhnout
2023-05-09 00:00:0010-QStáhnout
2023-05-04 01:00:008-KStáhnout
2023-05-04 00:00:008-KStáhnout
2023-03-13 00:00:008-KStáhnout
2023-03-12 23:00:008-KStáhnout
2023-02-28 00:00:008-KStáhnout
2023-02-28 00:00:0010-KStáhnout
2023-02-27 23:00:008-KStáhnout
2023-02-27 23:00:0010-KStáhnout
2023-01-09 00:00:008-KStáhnout
2023-01-08 23:00:008-KStáhnout
2022-11-28 00:00:008-KStáhnout
2022-11-27 23:00:008-KStáhnout
2022-11-14 00:00:008-KStáhnout
2022-11-14 00:00:0010-QStáhnout
2022-11-13 23:00:008-KStáhnout
2022-11-13 23:00:0010-QStáhnout
2022-10-13 01:00:008-KStáhnout
2022-10-13 00:00:008-KStáhnout
2022-10-03 01:00:008-KStáhnout
2022-10-03 00:00:008-KStáhnout
2022-09-15 01:00:008-KStáhnout
2022-09-15 00:00:008-KStáhnout
2022-08-12 01:00:008-KStáhnout
2022-08-12 01:00:0010-QStáhnout
2022-08-12 00:00:008-KStáhnout
2022-08-12 00:00:0010-QStáhnout
2022-06-21 01:00:008-KStáhnout
2022-06-21 00:00:008-KStáhnout
2022-05-25 01:00:008-KStáhnout
2022-05-25 00:00:008-KStáhnout
2022-05-12 01:00:008-KStáhnout
2022-05-12 01:00:0010-QStáhnout
2022-05-12 00:00:008-KStáhnout
2022-05-12 00:00:0010-QStáhnout
2022-04-13 01:00:008-KStáhnout
2022-04-13 00:00:008-KStáhnout
2022-03-30 01:00:008-KStáhnout
2022-03-30 01:00:0010-KStáhnout
2022-03-30 00:00:008-KStáhnout
2022-03-30 00:00:0010-KStáhnout
2022-03-25 00:00:008-KStáhnout
2022-03-24 23:00:008-KStáhnout
2022-03-18 00:00:008-KStáhnout
2022-03-17 23:00:008-KStáhnout
2022-03-14 00:00:008-KStáhnout
2022-03-13 23:00:008-KStáhnout
2022-03-01 00:00:008-KStáhnout
2022-02-28 23:00:008-KStáhnout
2022-02-28 00:00:008-KStáhnout
2022-02-27 23:00:008-KStáhnout
2022-01-12 00:00:008-KStáhnout
2022-01-11 23:00:008-KStáhnout
2022-01-05 00:00:008-KStáhnout
2022-01-04 23:00:008-KStáhnout
2021-12-23 00:00:008-KStáhnout
2021-12-22 23:00:008-KStáhnout
2021-11-08 00:00:008-KStáhnout
2021-11-07 23:00:008-KStáhnout
2021-11-05 00:00:008-KStáhnout
2021-11-05 00:00:0010-QStáhnout
2021-11-04 23:00:008-KStáhnout
2021-11-04 23:00:0010-QStáhnout
2021-10-21 01:00:008-KStáhnout
2021-10-21 00:00:008-KStáhnout
2021-10-20 01:00:008-KStáhnout
2021-10-20 00:00:008-KStáhnout
2021-10-18 01:00:008-KStáhnout
2021-10-18 00:00:008-KStáhnout
2021-09-27 01:00:008-KStáhnout
2021-09-27 00:00:008-KStáhnout
2021-09-15 01:00:008-KStáhnout
2021-09-15 00:00:008-KStáhnout
2021-09-02 01:00:008-KStáhnout
2021-09-02 00:00:008-KStáhnout
2021-08-10 01:00:008-KStáhnout
2021-08-10 01:00:0010-QStáhnout
2021-08-10 00:00:008-KStáhnout
2021-08-10 00:00:0010-QStáhnout
2021-07-29 01:00:008-KStáhnout
2021-07-29 00:00:008-KStáhnout
2021-06-28 01:00:008-KStáhnout
2021-06-28 00:00:008-KStáhnout
2021-06-23 01:00:008-KStáhnout
2021-06-23 00:00:008-KStáhnout
2021-05-06 01:00:008-KStáhnout
2021-05-06 01:00:0010-QStáhnout
2021-05-06 00:00:008-KStáhnout
2021-05-06 00:00:0010-QStáhnout
2021-04-08 01:00:008-KStáhnout
2021-04-08 00:00:008-KStáhnout
2021-03-30 01:00:008-KStáhnout
2021-03-30 01:00:0010-KStáhnout
2021-03-30 00:00:008-KStáhnout
2021-03-30 00:00:0010-KStáhnout
2021-02-04 00:00:008-KStáhnout
2021-02-03 23:00:008-KStáhnout
2021-02-03 00:00:008-KStáhnout
2021-02-02 23:00:008-KStáhnout
2021-01-06 00:00:008-KStáhnout
2021-01-05 23:00:008-KStáhnout
2020-11-06 00:00:008-KStáhnout
2020-11-06 00:00:0010-QStáhnout
2020-11-05 23:00:008-KStáhnout
2020-11-05 23:00:0010-QStáhnout
2020-10-26 00:00:008-KStáhnout
2020-10-25 23:00:008-KStáhnout
2020-09-21 01:00:008-KStáhnout
2020-09-21 00:00:008-KStáhnout
2020-09-03 01:00:008-KStáhnout
2020-09-03 00:00:008-KStáhnout
2020-08-07 01:00:008-KStáhnout
2020-08-07 01:00:0010-QStáhnout
2020-08-07 00:00:008-KStáhnout
2020-08-07 00:00:0010-QStáhnout
2020-06-22 01:00:008-KStáhnout
2020-06-22 00:00:008-KStáhnout
2020-05-08 01:00:008-KStáhnout
2020-05-08 01:00:0010-QStáhnout
2020-05-08 00:00:008-KStáhnout
2020-05-08 00:00:0010-QStáhnout
2020-04-15 01:00:008-KStáhnout
2020-04-15 00:00:008-KStáhnout
2020-04-14 01:00:008-KStáhnout
2020-04-14 00:00:008-KStáhnout
2020-04-06 01:00:008-KStáhnout
2020-04-06 00:00:008-KStáhnout
2020-03-09 00:00:008-KStáhnout
2020-03-09 00:00:0010-KStáhnout
2020-03-08 23:00:008-KStáhnout
2020-03-08 23:00:0010-KStáhnout
2019-11-12 00:00:008-KStáhnout
2019-11-12 00:00:0010-QStáhnout
2019-11-11 23:00:008-KStáhnout
2019-11-11 23:00:0010-QStáhnout
2019-08-13 01:00:008-KStáhnout
2019-08-13 01:00:0010-QStáhnout
2019-08-13 00:00:008-KStáhnout
2019-08-13 00:00:0010-QStáhnout
2019-07-16 01:00:008-KStáhnout
2019-07-16 00:00:008-KStáhnout
2019-06-25 01:00:008-KStáhnout
2019-06-25 00:00:008-KStáhnout
2019-05-13 01:00:008-KStáhnout
2019-05-13 01:00:0010-QStáhnout
2019-05-13 00:00:008-KStáhnout
2019-05-13 00:00:0010-QStáhnout
2019-04-12 01:00:008-KStáhnout
2019-04-12 00:00:008-KStáhnout
2019-03-13 00:00:008-KStáhnout
2019-03-13 00:00:0010-KStáhnout
2019-03-12 23:00:008-KStáhnout
2019-03-12 23:00:0010-KStáhnout
2018-11-13 00:00:008-KStáhnout
2018-11-13 00:00:0010-QStáhnout
2018-11-12 23:00:008-KStáhnout
2018-11-12 23:00:0010-QStáhnout
2018-10-01 01:00:008-KStáhnout
2018-10-01 00:00:008-KStáhnout
2018-08-30 01:00:008-KStáhnout
2018-08-30 01:00:0010-QStáhnout
2018-08-30 00:00:008-KStáhnout
2018-08-30 00:00:0010-QStáhnout
2018-07-20 01:00:008-KStáhnout
2018-07-20 00:00:008-KStáhnout
preloader